InsidersTradesSigma
Browse the complete record of transactions filed by Nandabalan Krishnan, Director. Director active across 1 companies, notably BioXcel Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €24.5m. The latest transaction was filed on 25 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Krishnan Nandabalan is a Board Member of BioXcel Therapeutics, Inc. He brings expertise in corporate strategy and governance. His role on the board allows him to actively participate in strategic decision-making for the company. Through his experience, he helps guide growth initiatives and strengthen BioXcel's market position.